Latest Working Capital Management News

Codan Limited has delivered a robust FY25 performance, with revenue up 22% and net profit rising 27%, underpinned by strong growth in its Communications and Metal Detection segments. The company also announced a 27% increase in dividends and a significant reduction in net debt.

Medical Developments International has reported a remarkable turnaround in FY25, posting a net profit after tax and securing paediatric approval for its flagship product Penthrox in Europe.

Medical Developments International reports a strong FY25 with significant margin gains and strategic progress, setting the stage for accelerated Penthrox expansion in FY26.

Maas Group Holdings Ltd reported a 6% rise in FY25 underlying EBITDA to $219.4 million, driven by robust growth in Construction Materials and Commercial Real Estate. The company’s disciplined capital management and strategic acquisitions set a positive tone for FY26.

Bega Cheese Limited reported a robust FY2025 with a 23% rise in normalised EBITDA, driven by strong branded product growth and a turnaround in its Bulk segment. The company forecasts further gains in FY2026 with new product launches and operational efficiencies.

Maas Group Holdings reported FY25 underlying EBITDA of $219.4 million, matching guidance, with a robust 97% cash conversion and an 8% increase in dividends. The company’s Construction Materials division drove growth despite challenges in Civil Construction.

Saunders International reported a modest revenue dip and sharp profit decline in FY2025, offset by a transformative acquisition that expands its water infrastructure footprint and doubles its project pipeline.

Service Stream Limited has reported a robust FY2025 with revenue climbing to $2.42 billion and a significant 13.1% rise in underlying EBITDA, alongside a 22% increase in dividends, underscoring its strong market position and operational execution.

CSL Limited reported robust FY25 results alongside a sweeping strategic overhaul, including a major cost-saving program and plans to spin off its vaccine unit CSL Seqirus as a standalone ASX-listed company.

Simonds Group delivered stable FY25 revenue and modest EBITDA growth despite one-off acquisition expenses, positioning itself for growth through strategic product and channel expansion in FY26.

Simonds Group Limited reported steady revenue of $665.6 million for FY2025, alongside a modest net profit of $1.015 million, as it completed the strategic acquisition of Dennis Family Homes. The company is focused on integrating the acquisition and driving growth amid a recovering housing market.

Lendlease Group has returned to profitability in FY25 with a statutory profit of $225 million and a 44% increase in distributions, underpinned by significant capital recycling and cost savings. The group is poised for growth with a robust development pipeline and a strong construction backlog.